NUSIRT
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Althoug... h, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.
NUSIRT
Industry:
Biotechnology Clinical Trials Diabetes
Founded:
2007-01-01
Address:
Nashville, Tennessee, United States
Country:
United States
Website Url:
http://www.nusirt.com
Total Employee:
1+
Status:
Active
Contact:
(615) 810-8191
Email Addresses:
[email protected]
Total Funding:
15.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Wordpress Plugins Nginx Euro
Similar Organizations
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Tennessee Community Ventures
Tennessee Community Ventures investment in Series C - Nusirt
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series C - Nusirt
TriStar Health Partners
TriStar Health Partners investment in Series C - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series B - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Series A - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Series A - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Seed Round - Nusirt
Tennessee Community Ventures
Tennessee Community Ventures investment in Seed Round - Nusirt
Mountain Group Capital
Mountain Group Capital investment in Seed Round - Nusirt
Official Site Inspections
http://www.nusirt.com
- Host name: 189.28.212.35.bc.googleusercontent.com
- IP address: 35.212.28.189
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
